Возраст домена | n/a |
Дата окончания | n/a |
PR | 7 |
ИКС | |
Страниц в Google | 10700 |
Страниц в Яндексе | 4000 |
Dmoz | Да |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 165677 |
Alexa Country | 1372 |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Medsafe Home Page
n/a
n/a
UTF-8
15.74 КБ
410
3 583 симв.
3 076 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
medicines.org.uk | 2321 | 6 |
50 | 21875 | 1897 | |
canoe.com | 778 | 7 |
30 | 22855 | 737 | |
empr.com | 756 | 5 |
10 | 93864 | 25060 | |
mydr.com.au | 524 | 6 |
10 | 62211 | 2179 | |
inhousepharmacy.vu | 421 | 1 |
10 | 258345 | 86097 | |
epocrates.com | 388 | 7 |
0 | 46468 | 10451 | |
rxmed.com | 384 | 5 |
0 | 2893001 | Нет данных | |
nps.org.au | 352 | 6 |
20 | 42295 | 1207 | |
intekom.com | 340 | 4 |
10 | 303890 | 5889 | |
mhra.gov.uk | 173 | 6 |
80 | 198509 | 23363 | |
drugs.com | 33 | 7 |
0 | 3848 | 1398 | |
nhs.uk | 25 | 7 |
0 | Нет данных | Нет данных | |
nih.gov | 25 | 8 |
0 | 113 | 65 | |
patient.co.uk | 20 | 6 |
0 | 19976462 | Нет данных | |
wikipedia.org | 19 | 9 |
0 | 5 | 6 | |
webmd.com | 18 | 7 |
0 | 552 | 197 | |
netdoctor.co.uk | 14 | 6 |
0 | 26456 | 18104 | |
rxlist.com | 13 | 7 |
0 | 7347 | 1874 | |
everydayhealth.com | 11 | 7 |
0 | 3797 | 1943 | |
Еще 31 сайт после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 10 Ноября 2016 ) | |
Количество ссылок на сайт | 5927 |
Количество доменов, которые ссылаются на сайт | 976 |
Количество найденных анкоров | 1058 |
Исходящие (внешние) ссылки домена | 1990 |
Количество доменов, на которые ссылается сайт | 126 |
Количество исходящих анкоров | 259 |
Внешние ссылки главной страницы ( 2 ) | |
govt.nz/ | / |
health.govt.nz/ | <img> |
Внутренние ссылки главной страницы ( 81 ) | |
index.asp | 1 |
Medicines/medicines-landing.asp | Medicines |
Medicines/medicine-information.asp | Medicine Information |
Medicines/regulatory-approval-process.asp | Approval Process |
Medicines/regulatory-landing.asp | Regulatory Guidance |
Medicines/clinical-trials.asp | Clinical Trials |
profs/class/clascon.asp | Classification |
Medicines/manufacturing.asp | Manufacturing |
devices/devices-landing.asp | Devices |
regulatory/DevicesNew/3WAND.asp | WAND |
regulatory/DevicesNew/industry.asp | Regulatory Guidance |
devices/Surgical%20Mesh/Landing.asp | Surgical Mesh |
regulatory/DevicesNew/safety.asp | Safety Information |
hot/ProductRecallInformation/ProductRecallHome.asp | Product Recalls |
devices/education-and-information.asp | Device Information |
safety/safety-landing.asp | Safety |
safety/education-and-information.asp | Safety Information |
safety/alerts.asp | Safety Communications |
safety/ADR-reporting.asp | Adverse Reaction Reporting |
compliance/compliance-landing.asp | Compliance |
profs/RIss/unapp.asp | Unapproved Medicines |
compliance/advertising.asp | Marketing |
compliance/importing-medicines.asp | Importing Medicines |
publications/publications-landing.asp | Publications |
hot/MediaContents.asp | Media |
publications/prescriber-update.asp | 6 |
publications/oia.asp | OIA Releases |
consultations/consultations-landing.asp | Consultations |
consultations/current.asp | Consultation on proposed changes to current warning and advisory statements for paracetamol |
consultations/closed.asp | Closed |
consultations/outcome.asp | Outcomes |
committees/committees-landing.asp | Committees |
committees/mcc.asp | Medicines Classification |
committees/maac.asp | Medicines Assessment Advisory |
committees/marc.asp | Medicines Adverse Reactions |
other/about.asp | Our Role |
other/new.asp | What's New |
other/contact.asp | 9 |
other/people.asp | Our People |
about/HistoryRegulation/HistoryRegulationContents.asp | History |
profs/PUarticles.asp | Prescriber Update Volume 40 Number 4 dated December 2019 |
Consumers/cons.asp | More... |
Medicines/infoSearch.asp | 5 |
Consumers/MIET/ImportMedicines.asp | Personal Importation of Medicines |
Consumers/educational-material.asp | Consumer Information Leaflets |
safety/report-a-problem.asp | How to Report a Problem |
profs/profs.asp | More... |
profs/ADR-training/story.html | ADR eLearning |
regulatory/reg.asp | More... |
/WAND/ | 7 |
regulatory/DietarySupplements/Regulation.asp | Dietary Supplements |
regulatory/forms.asp | Forms and Templates |
regulatory/current-guidelines.asp | Regulatory Guidelines |
regulatory/fees.asp | Schedule of Fees |
Medicines/policy-statements/Out%20of%20Stock.asp | Out of Stock |
regulatory/DbSearch.asp | Product/Application for Medicines |
Projects/B1/ADRSearch.asp | Adverse Reactions |
hot/Recalls/RecallSearch.asp | Recalls |
profs/class/classintro.asp | Classification |
regulatory/labelling.asp | Label Statements |
publications/media/2019/MCCMinutes.asp | Medicines Classification Committee releases latest meeting minutes |
profs/class/Minutes/2016-2020/mccMin10Oct2019.htm | Minutes of the 63rd meeting of the Medicines Classification Committee held in Wellington on 10 October 2019 |
profs/class/dates.asp | Medicines Classification Committee - Dates and Deadlines |
compliance/Marketing.asp | Marketing products which are not approved medicines |
publications/media/2019/TakingMultipleMedicines.asp | Taking multiple medicines? Support the health care system by reporting suspected side effects this #MedSafetyWeek |
committees/marc/Agenda180-5Dec2019.htm | Agenda for the 180th Medicines Adverse Reactions Committee meeting - 5 December 2019 |
safety/Alerts/Cafergot%20Prohibited.asp | Consent to distribute Cafergot tablets (ergotamine tartrate 1 mg + caffeine 100 mg) will be prohibited under Section 36 of the M... |
safety/Alerts/Dabigatran.asp | Possible risk of vasculitis with dabigatran (Pradaxa) |
safety/Alerts/BreastImplants.asp | Update 7 November 2019 - Breast Implants and anaplastic large cell lymphoma |
safety/Alerts/Lamotrigine.asp | Suspected adverse reaction reports to lamotrigine after changing brands |
safety/Alerts/Everet.asp | Everet (levetiracetam) - supply and potential seizure control issues for patients |
hot/RecallActionNoticesNew/25236.asp | Consumer level recall of one lot of Avonex Pen 30mcg in 0.5mL, Lot 1422362 |
profs/adverse/Minutes179.htm | Minutes of the 179th Medicines Adverse Reactions Committee Meeting |
safety/Alerts/MedicinesAndNDMA.asp | Medicines containing ranitidine and a potential impurity, N-nitrosodimethylamine (NDMA) |
safety/Alerts/Losartan.asp | Losartan approved medicines supplied in New Zealand not affected by recalls overseas |
safety/Alerts/NitrosamineImpurity.asp | Review of chemically synthesised active pharmaceutical ingredients for presence of nitrosamine impurity |
other/siteinfo.asp | About this Site |
faq-index.asp | FAQs |
sitemap.htm | 2 |
other/accesskeys.asp | 0 |
#page-content | [ |
США - 67.202.219.28
SunGard Availability Services LP
Sungard Network Solutions
HTTP/1.1 200 OK
Cache-Control: private
Content-Length: 16115
Content-Type: text/html
Server: Microsoft-IIS/8.5
Set-Cookie: ASPSESSIONIDCGAQTSRD=MIPKDNBDFDOMBCJOMFMIKGKG; secure; path=/
X-Powered-By: ASP.NET
Date: Mon, 16 Dec 2019 02:13:07 GMT
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"